Cortland Associates’s Core Laboratories CLB Stock Holding History

Cortland Associates’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-40,162	Closed	-$5.88M	–	39
2014 Q3	$5.88M	Buy	+40,162	New	+$6.2M	1.4%	16

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cortland Associates's CLB Position: Q4 2014 in Review

Cortland Associates sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 40,162 shares — an estimated $5.88M sold.

Cortland Associates first reported a position in CLB in Q3 2014 and held it in 1 quarter. The position peaked at $5.88M in Q3 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

Cortland Associates reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
Cortland Associates sold 40,162 Core Laboratories shares in Q4 2014, an estimated $5.88M.
Cortland Associates first reported a position in Core Laboratories in Q3 2014 and held it in 1 quarter.
Cortland Associates's Core Laboratories position peaked at $5.88M in Q3 2014.
345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Cortland Associates's 13F filing for Q4 2014, filed 13 Feb 2015.